| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00018-017-2708-5 |
| P698 | PubMed publication ID | 29119229 |
| P2093 | author name string | Yves St-Pierre | |
| Cherylane Dubé-Delarosbil | |||
| P2860 | cites work | Nicotine-induced resistance of non-small cell lung cancer to treatment--possible mechanisms | Q26768163 |
| Immunotherapy for hepatocellular carcinoma | Q26775188 | ||
| Liver transplantation for hepatocellular carcinoma | Q26775214 | ||
| The Role of Glycosylation in Breast Cancer Metastasis and Cancer Control | Q26777141 | ||
| Global trends of lung cancer mortality and smoking prevalence | Q26784117 | ||
| Nuclear transport of galectin-3 and its therapeutic implications | Q26824889 | ||
| Glioblastoma cancer stem cells: Biomarker and therapeutic advances | Q26859782 | ||
| Immunotherapy for brain cancer: recent progress and future promise | Q27015881 | ||
| Global cancer statistics, 2012 | Q27860501 | ||
| Galectins: Double-edged Swords in the Cross-roads of Pregnancy Complications and Female Reproductive Tract Inflammation and Neoplasia | Q28081459 | ||
| Epidemiologic and molecular prognostic review of glioblastoma | Q28395302 | ||
| Galectin-1-Induced Autophagy Facilitates Cisplatin Resistance of Hepatocellular Carcinoma | Q28550036 | ||
| Expression and functions of galectin-7 in ovarian cancer. | Q30594259 | ||
| Galectin-1 is implicated in the protein kinase C epsilon/vimentin-controlled trafficking of integrin-beta1 in glioblastoma cells | Q33588193 | ||
| Identification of galectin-7 as a potential biomarker for esophageal squamous cell carcinoma by proteomic analysis | Q33603811 | ||
| Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness | Q33692511 | ||
| Small cell lung cancer: where do we go from here? | Q33872327 | ||
| Galectin-3 facilitates cell motility in gastric cancer by up-regulating protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1). | Q34037992 | ||
| Global patterns of cancer incidence and mortality rates and trends | Q34127168 | ||
| Galectin-4 expression is associated with reduced lymph node metastasis and modulation of Wnt/β-catenin signalling in pancreatic adenocarcinoma | Q34221829 | ||
| Galectin-3 as a marker and potential therapeutic target in breast cancer | Q34257030 | ||
| Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma | Q34265995 | ||
| Galectin-1, a gene preferentially expressed at the tumor margin, promotes glioblastoma cell invasion. | Q34268364 | ||
| Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity | Q34343335 | ||
| Galectins as modulators of tumour progression | Q34381235 | ||
| Overexpressed galectin-3 in pancreatic cancer induces cell proliferation and invasion by binding Ras and activating Ras signaling | Q34382553 | ||
| Plasma levels of galectin-3-binding protein reflect type I interferon activity and are increased in patients with systemic lupus erythematosus | Q34583337 | ||
| Galectin-3 functions as an alarmin: pathogenic role for sepsis development in murine respiratory tularemia | Q34635334 | ||
| Novel roles of galectin-1 in hepatocellular carcinoma cell adhesion, polarization, and in vivo tumor growth. | Q39578275 | ||
| Lung cancer-derived galectin-1 mediates dendritic cell anergy through inhibitor of DNA binding 3/IL-10 signaling pathway | Q39614587 | ||
| Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma | Q77392016 | ||
| Multiplexed proximity ligation assays to profile putative plasma biomarkers relevant to pancreatic and ovarian cancer | Q80436671 | ||
| Malignant mesothelioma | Q80961479 | ||
| Impact of nuclear galectin-3 expression on histological differentiation and vascular invasion in patients with esophageal squamous cell carcinoma | Q81253787 | ||
| Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices | Q81522507 | ||
| Li-cadherin is inversely correlated with galectin-3 expression in gastric cancer | Q81591712 | ||
| Nuclear galectin-3 expression is an independent predictive factor of recurrence for adenocarcinoma and squamous cell carcinoma of the lung | Q81653150 | ||
| A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound | Q82068160 | ||
| [Expression of galectin-3 mRNA in gastric cancer with peritoneal metastasis] | Q82513514 | ||
| Transient silencing of galectin-3 expression promotes both in vitro and in vivo drug-induced apoptosis of human pancreatic carcinoma cells | Q83436389 | ||
| Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection | Q83701996 | ||
| CCL2, galectin-3, and SMRP combination improves the diagnosis of mesothelioma in pleural effusions | Q84447721 | ||
| High expression of Galectin-1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer | Q84584414 | ||
| microRNA-22 downregulation of galectin-9 influences lymphocyte apoptosis and tumor cell proliferation in liver cancer | Q85713148 | ||
| Identification of novel markers for the diagnosis of malignant pleural mesothelioma | Q34760760 | ||
| Galectin-4 Reduces Migration and Metastasis Formation of Pancreatic Cancer Cells | Q34793403 | ||
| Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma | Q34797866 | ||
| Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays | Q34928555 | ||
| Decreased galectin-9 and increased Tim-3 expression are related to poor prognosis in gastric cancer | Q35067641 | ||
| Galectin-4, a novel predictor for lymph node metastasis in lung adenocarcinoma | Q35067654 | ||
| Pancreatic satellite cells derived galectin-1 increase the progression and less survival of pancreatic ductal adenocarcinoma | Q35111396 | ||
| Galectin-3 up-regulation in hypoxic and nutrient deprived microenvironments promotes cell survival | Q35392528 | ||
| Alarmin function of galectin-9 in murine respiratory tularemia | Q35515960 | ||
| Galectin-1 is overexpressed in CD133+ human lung adenocarcinoma cells and promotes their growth and invasiveness. | Q35550185 | ||
| Integrated Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) and Isobaric Tags for Relative and Absolute Quantitation (iTRAQ) Quantitative Proteomic Analysis Identifies Galectin-1 as a Potential Biomarker for Predicting Sorafenib Resist | Q35692109 | ||
| Expression of galectin-1 in carcinoma-associated fibroblasts promotes gastric cancer cell invasion through upregulation of integrin β1. | Q35713332 | ||
| Galectin-4 serves as a prognostic biomarker for the early recurrence / metastasis of hepatocellular carcinoma | Q35713459 | ||
| Galectin-3 augments tumor initiating property and tumorigenicity of lung cancer through interaction with β-catenin | Q35741579 | ||
| Lung cancer-derived galectin-1 enhances tumorigenic potentiation of tumor-associated dendritic cells by expressing heparin-binding EGF-like growth factor | Q35879907 | ||
| Galectin-1 as a potential cancer target | Q36078029 | ||
| Galectin 3 regulates HCC cell invasion by RhoA and MLCK activation | Q36101399 | ||
| CXCR7 stimulates MAPK signaling to regulate hepatocellular carcinoma progression | Q36291113 | ||
| Expression of galectin-9 mRNA in hepatocellular carcinoma | Q36464828 | ||
| Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysis | Q36630997 | ||
| Clinicopathological and prognostic significance of galectin-1 and vascular endothelial growth factor expression in gastric cancer | Q36759226 | ||
| Serum markers for predicting pre-eclampsia | Q36833201 | ||
| Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling | Q36866377 | ||
| Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets | Q37109711 | ||
| Potential markers of preeclampsia--a review | Q37278804 | ||
| Galectin-7 is epigenetically-regulated tumor suppressor in gastric cancer | Q37299306 | ||
| Lung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune suppression through TDO2/kynurenine axis | Q37317333 | ||
| Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of β-catenin | Q37322616 | ||
| Galectin-9 plasma levels reflect adverse hematological and immunological features in acute dengue virus infection. | Q37432401 | ||
| First-trimester maternal serum PP13 in the risk assessment for preeclampsia. | Q37444801 | ||
| Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma | Q37623620 | ||
| Gallbladder cancer: epidemiology and outcome | Q37635412 | ||
| The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science | Q37720601 | ||
| The progress of proteomic approaches in searching for cancer biomarkers | Q38060959 | ||
| 'Sweetening' pregnancy: galectins at the fetomaternal interface | Q38081185 | ||
| p53 transactivation is involved in the antiproliferative activity of the putative tumor suppressor RBM5. | Q39724417 | ||
| Silencing of galectin-3 changes the gene expression and augments the sensitivity of gastric cancer cells to chemotherapeutic agents | Q39785502 | ||
| Galectin-3 increases gastric cancer cell motility by up-regulating fascin-1 expression | Q39789149 | ||
| Suppression of galectin-3 expression enhances apoptosis and chemosensitivity in liver fluke-associated cholangiocarcinoma | Q39805315 | ||
| Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons | Q39874836 | ||
| Role of galectin-1 in migration and invasion of human glioblastoma multiforme cell lines | Q39955272 | ||
| Knocking down galectin 1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses | Q39989272 | ||
| Pancreatic stellate cells promote proliferation and invasiveness of human pancreatic cancer cells via galectin-3 | Q39994161 | ||
| Evidence of galectin-1 involvement in glioma chemoresistance | Q40006970 | ||
| Galectin-3 may contribute to Cisplatin resistance in clear cell carcinoma of the ovary | Q40145990 | ||
| Galectin-7 in lymphoma: elevated expression in human lymphoid malignancies and decreased lymphoma dissemination by antisense strategies in experimental model | Q40158300 | ||
| Galectin-1 knocking down in human U87 glioblastoma cells alters their gene expression pattern | Q40392221 | ||
| Multifaceted role of galectin-3 on human glioblastoma cell motility | Q40489819 | ||
| Galectin-3: differential expression between small-cell and non-small-cell lung cancer | Q40521621 | ||
| Role of galectin-3 in plasma as a predictive biomarker of outcome after acute intracerebral hemorrhage | Q40616519 | ||
| Galectin-3 expression alters adhesion, motility and invasion in a lung cell line (DLKP), in vitro. | Q40677265 | ||
| Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas | Q40733113 | ||
| Expression of endogenous galectin-1 and galectin-3 in intrahepatic cholangiocarcinoma | Q40817943 | ||
| Concentrations of galectin-3 in the sera of normal controls and cancer patients | Q40884459 | ||
| Anginex, a designed peptide that inhibits angiogenesis | Q41874982 | ||
| Targeting Galectin-1 in pancreatic cancer: immune surveillance on guard | Q42030543 | ||
| Expression of adhesion factors and degrading proteins in primary and secondary glioblastomas and their precursor tumors | Q42485404 | ||
| Galectin-3 germline variant at position 191 enhances nuclear accumulation and activation of β-catenin in gastric cancer | Q42730725 | ||
| Galectin-3 binds to MUC1-N-terminal domain and triggers recruitment of β-catenin in MUC1-expressing mouse 3T3 cells | Q42806313 | ||
| Anaplastic glioma: how to prognosticate outcome and choose a treatment strategy. [corrected]. | Q43245400 | ||
| Role of galectin-3 in adenocarcinoma liver metastasis | Q43769106 | ||
| Deregulated expression of annexin-A2 and galectin-3 is associated with metastasis in gastric cancer patients | Q44253238 | ||
| Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma. | Q45358316 | ||
| Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity. | Q45945651 | ||
| Expression of Gal-3 and CD82/KAI1 proteins in non-small cell lung cancer and their clinical significance | Q46052125 | ||
| Expression of galectin-3 involved in prognosis of patients with hepatocellular carcinoma | Q46442908 | ||
| Galectin-1 induces chemokine production and proliferation in pancreatic stellate cells | Q46864651 | ||
| Galectins: a family of animal beta-galactoside-binding lectins | Q48084852 | ||
| Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases | Q48543365 | ||
| Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system | Q48637099 | ||
| Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma | Q48958266 | ||
| Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration. | Q49108957 | ||
| Up-regulation of galectin-3 and Sambucus nigra agglutinin binding site is associated with invasion, metastasis and poor-progression of the gallbladder adenocarcinoma | Q50174633 | ||
| Galectin-3 knockdown increases gefitinib sensitivity to the inhibition of EGFR endocytosis in gefitinib-insensitive esophageal squamous cancer cells. | Q50997794 | ||
| Increased levels of galectin-3 were associated with prediabetes and diabetes: new risk factor? | Q51311008 | ||
| RN1, a novel galectin-3 inhibitor, inhibits pancreatic cancer cell growth in vitro and in vivo via blocking galectin-3 associated signaling pathways. | Q51518944 | ||
| [Serum and tissue expressions of galectin-3 in hepatocellular carcinoma and the clinical significances]. | Q53277840 | ||
| Galectin-1 Controls the Proliferation and Migration of Liver Sinusoidal Endothelial Cells and Their Interaction With Hepatocarcinoma Cells. | Q53284113 | ||
| Evidence for the role of 34-kDa galactoside-binding lectin in transformation and metastasis. | Q53503954 | ||
| Apoptosis and anergy of T cell induced by pancreatic stellate cells-derived galectin-1 in pancreatic cancer. | Q53600526 | ||
| Clinical significance of galectin-7 in epithelial ovarian cancer. | Q54264856 | ||
| Expression of galectin-1 mRNA correlates with the malignant potential of human gliomas and expression of antisense galectin-1 inhibits the growth of 9 glioma cells. | Q55476008 | ||
| Clinical significance of circulating galectins as colorectal cancer markers | Q56601187 | ||
| Gallbladder cancer | Q57653775 | ||
| Galectin-3 expression in non-small cell lung carcinoma | Q57893121 | ||
| Comparative analysis of galectins in primary tumors and tumor metastasis in human pancreatic cancer | Q73644483 | ||
| Localization of galectin-3 in normal and diseased pancreatic tissue | Q74372136 | ||
| Immunohistochemical profile of galectin-8 expression in benign and malignant tumors of epithelial, mesenchymatous and adipous origins, and of the nervous system | Q74393002 | ||
| Management of non-small-cell lung cancer: recent developments | Q38131165 | ||
| Treatment of hepatocellular carcinoma: a systematic review | Q38155508 | ||
| Intracellular galectins in cancer cells: potential new targets for therapy (Review). | Q38180976 | ||
| Expression, localization and function of galectin-8, a tandem-repeat lectin, in human tumors | Q38201698 | ||
| Galectin-3 in diabetic patients | Q38221153 | ||
| Non-small-cell lung cancers: a heterogeneous set of diseases | Q38233321 | ||
| Galectin-3 inhibitors: a patent review (2008-present). | Q38238525 | ||
| Targeted disruption of the galectin-3 gene results in decreased susceptibility to NNK-induced lung tumorigenesis: an oligonucleotide microarray study | Q38294425 | ||
| Galectin-3 expressed on different lung compartments promotes organ specific metastasis by facilitating arrest, extravasation and organ colonization via high affinity ligands on melanoma cells. | Q38306237 | ||
| Targeting specific molecular pathways holds promise for advanced gallbladder cancer therapy. | Q38339507 | ||
| Molecular targeted therapy in the treatment of advanced stage non-small cell lung cancer (NSCLC). | Q38358410 | ||
| Targeted therapy for non-small cell lung cancer: current standards and the promise of the future | Q38390200 | ||
| Galectin-3 and aldosterone as potential tandem biomarkers in pulmonary arterial hypertension | Q38410318 | ||
| Prognostic value of galectin-3 in patients with heart failure | Q38471023 | ||
| Galectin-1 inhibitors and their potential therapeutic applications: a patent review | Q38763827 | ||
| Knockdown of LI-cadherin alters expression of matrix metalloproteinase-2 and -9 and galectin-3. | Q38781609 | ||
| Galectin-9: An anticancer molecule for gallbladder carcinoma | Q38800628 | ||
| Galectin-9 suppresses the proliferation of gastric cancer cells in vitro | Q38807956 | ||
| Galectin-3 modulates the EGFR signalling-mediated regulation of Sox2 expression via c-Myc in lung cancer | Q38829578 | ||
| Galectin-9 suppresses cholangiocarcinoma cell proliferation by inducing apoptosis but not cell cycle arrest | Q38844680 | ||
| Galectin-9 suppresses the growth of hepatocellular carcinoma via apoptosis in vitro and in vivo | Q38893144 | ||
| Expression of mucin 1 possessing a 3'-sulfated core1 in recurrent and metastatic breast cancer | Q38897800 | ||
| Galectin-1 triggers epithelial-mesenchymal transition in human hepatocellular carcinoma cells | Q38932655 | ||
| Peroxisome proliferator-activated receptor γ upregulates galectin-9 and predicts prognosis in intestinal-type gastric cancer. | Q38979843 | ||
| Galectin-3 and matrix metalloproteinase-9: Perspective in management of hepatocellular carcinoma. | Q38983451 | ||
| Role of downregulation of galectin-9 in the tumorigenesis of gastric cancer | Q38985834 | ||
| Downregulation of galectin-3 causes a decrease in uPAR levels and inhibits the proliferation, migration and invasion of hepatocellular carcinoma cells | Q38997262 | ||
| An EpCAM/CD3 bispecific antibody efficiently eliminates hepatocellular carcinoma cells with limited galectin-1 expression | Q39068110 | ||
| Galectin-1 promotes lung cancer tumor metastasis by potentiating integrin α6β4 and Notch1/Jagged2 signaling pathway | Q39198397 | ||
| Galectin-9 acts as a prognostic factor with antimetastatic potential in hepatocellular carcinoma. | Q39287639 | ||
| Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2. | Q39331669 | ||
| Galectin-9 signaling prolongs survival in murine lung-cancer by inducing macrophages to differentiate into plasmacytoid dendritic cell-like macrophages | Q39426827 | ||
| Galectin-1 secreted by activated stellate cells in pancreatic ductal adenocarcinoma stroma promotes proliferation and invasion of pancreatic cancer cells: an in vitro study on the microenvironment of pancreatic ductal adenocarcinoma | Q39508641 | ||
| P577 | publication date | 2017-11-08 | |
| P1433 | published in | Cellular and Molecular Life Sciences | Q5058352 |
| P1476 | title | The emerging role of galectins in high-fatality cancers |
Search more.